Gilteritinib fumarate is the fumarate salt form of gilteritinib, an orally bioavailable inhibitor of receptor tyrosine kinases including FLT3, AXL, ALK, and LTK. It is used as an active pharmaceutical ingredient in manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Gilteritinib fumarate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Gilteritinib
pharmaceutical raw material
(6S)-rotigotine hydrochloride
pharmaceutical raw material
Ledipasvir
pharmaceutical raw material
N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester
pharmaceutical raw material
Alectinib
pharmaceutical raw material
(E)-but-2-enedioic acid;bis(6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide)
UJOUWHLYTQFUCU-WXXKFALUSA-N
CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5.CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5.C(=C/C(=O)O)\C(=O)O
Sourcing Gilteritinib fumarate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.